Schmidt, MD, PhD
Vice President and Head, Quintiles’ Phase I Drug Research Unit, London
Oliver Schmidt, M.D., Ph.D., oversees Quintiles’ Early Phase Drug Research Unit on the campus of Guy’s Hospital in London. Dr. Schmidt has more than 20 years of experience in clinical medicine, basic research and drug development, stretching from candidate selection to application for marketing authorization, with an emphasis on translational medicine and clinical pharmacology. During his career, he has held positions in clinical medicine, academia, biopharmaceutical companies and contract research organizations. Dr. Schmidt’s therapeutic expertise includes inflammatory, respiratory, metabolic and vascular diseases, as well as chronic pain.
Prior to joining Quintiles, Dr. Schmidt held senior medical positions at a number of large global pharmaceutical companies including AstraZeneca, Novartis and most recently, Takeda where he was a Senior Medical Director in Respiratory Medicine. Dr. Schmidt received his medical degree at the University of Münster, Germany, and his Ph.D. in developmental neurobiology from the University of Edinburgh, UK.